AstraZeneca International - pharmaceutical company, prescription drugs, medicine manufacturers

Go to navigation
Go to content

Reference code :: wf455
Published date :: 05 November 2002
Expired date :: 23 March 2030

AstraZeneca’s initial detailed review of the Court’s October 11th 2002 opinion relating to KUDCo and Schwarz Pharma has revealed that the Court made reversible errors in determining key facts and applying the law. AstraZeneca has therefore decided to appeal the portions of the Court’s judgement relating to KUDCo and Schwarz Pharma.

Further enquires to:

Media Enquiries

Steve Brown
+44 (0)20 7304 5033

Chris Major
+44 (0)20 7304 5028

Emily Denney
+44 (0)20 7304 5034

Investor Relations

Mina Blair-Robinson
+44 (0)20 7304 5084

Jonathan Hunt
+44 (0)20 7304 5087

Not signed in

Page tools

Share price

London: 26.95 GBP
New York: 44.82 USD
Stockholm: 310.10 SEK

At 21-Nov-2009 10:24 GMT

Detailed share price

Introduction to AstraZeneca

Our responsibility

We continue to communicate openly on a range of issues, including:

Contact us

Stay in touch

Subscribe via RSS

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.